The Peter Attia Drive

The Peter Attia Drive

#22 - Tom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins

Oct 17, 2018 · 01:04:13

Listen to Episode

✨ AI Summary

In-depth look at HDL, reverse cholesterol transport, and apolipoproteins.
Explains the nuances of HDL function beyond basic understanding.
Discusses CETP inhibitor trials and the complexity of lipid transport.

Guests on This Episode

CI

CETP inhibitors

1 podcast appearance

TD

Tom Dayspring

5 podcast appearances

More from The Peter Attia Drive

#385 - AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more

Mar 23, 2026 · 18:52

#384 - Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention

Mar 16, 2026 · 52:40

#381 ‒ Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.

Jan 26, 2026 · 02:06:34

#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.

Jan 19, 2026 · 02:07:42

View all episodes →